JPRN-C000000156已完成2 期
A phase II trial of targeted busulfan and cyclophosphamide conditioning for allogeneic hematopoietic stem cell transplantation for hematological malignancies - Targeted busulfan and cyclophosphamide for allogeneic hematopoietic stem cell transplantation (C-SHOT 0301)
agoya Blood and Marrow Transplantation Group0 个研究点目标入组 50 人开始时间: 2005年9月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Uncontrollable and active infection (2) Positivity for HIV antibody and/or HBs antigen and/or HCV antibody (3) Graft manipulation such as T cell depletion (4) Impaired organ function (kidney; serum creatinine >2.0 mg/dl, Liver; aspartate aminotransferase more than 5 times high than upper limit or serum bilirubin >2.0mg/dl, heart; left ventricular ejection fraction less than 50%, lung; arterial oxygen saturation < 93% without oxygen inhalation.) (5) History of drug allergy used in the present conditioning or GVHD prophylaxis.
研究者
相似试验
已完成
不适用
Pharmacokinetic studies of Busulfan as part of conditioning therapy prior to allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisD47.1Chronic myeloproliferative diseaseMyelofibrosisDRKS00015217niversitätsklinikum Hamburg-Eppendorf37
已完成
2 期
BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's LymphomaNon-hodgkin LymphomaNCT03794167Soonchunhyang University Hospital75
已完成
2 期
Phase II Trial of Pentostatin and Targeted BusulfanHematologic MalignanciesNCT00496340H. Lee Moffitt Cancer Center and Research Institute42
Unknown
1 期
Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM)Multiple MyelomaNCT03795597Loyola University36
已完成
2 期
Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan RegimenLeukemiaMyelodysplastic SyndromeNCT00852163Baylor Research Institute20